Pfizer expects to produce Covid vaccine for years to come
Demand for Pfizer's Covid vaccine could bolster its revenues for years, the US drugs giant has said.In the first three months of 2021, the vaccine generated revenues of $3.5bn as governments scrambled to try to contain the pandemic.
The forecast is based on already-signed contracts for 1.6 billion vaccine doses to be delivered this year. "Based on what we've seen, we believe that a durable demand for our Covid-19 vaccine - similar to that of the flu vaccines - is a likely outcome," said chief executive Albert Bourla.Expenses and profit from the vaccine are split 50-50 between Pfizer and its German partner BioNTech.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
COVID-19: US regulators authorise use of Pfizer vaccine for ages 12 to 15The move offers protection for young people in the US before they head back to school in the autumn.
Læs mere »
COVID-19: Long COVID clinics may be needed beyond April next yearNHS England has spent £34m on opening 83 clinics but they could be necessary for longer than first thought.
Læs mere »
COVID-19: Pfizer says demand for vaccine could be long-lasting like flu jabUS drugs giant Pfizer has said demand for its COVID-19 vaccine could become 'durable' like flu jabs as it reported revenues of $3.5bn for the drug in the first quarter
Læs mere »
Pfizer forecasts $26bn from annual sales of Covid-19 vaccineVaccine will generate 73% more than forecast based on contracts signed until mid-April
Læs mere »
US hopes of herd immunity from Covid 'unlikely' due to vaccine uptake, say expertsHERD IMMUNITY in the coronavirus fight is ‘unlikely' for US citizens - due to vaccine hesitancy and the issue of mutations, experts say.
Læs mere »